The devices are indicated for spinal cord and deep brain stimulation. The product can be controlled through a mobile app, including halting therapy to begin magnetic resonance imaging. Abbott said some patients have reported being unable to exit the MRI mode from the app, which could require surgery to replace the device.
Customers for about 155,000 Proclaim and Infinity systems have been notified after Abbott recorded 73 injuries and 186 incidents. The company instructed implanting surgeons to advise patients to not delete bluetooth connection between their phone and the device.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
